NEPHROS, INC. Research and Development Expense
NEPHROS, INC. (NEPH) reported Research and Development Expense of $366.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-10
- NEPHROS, INC. research and development expense for the quarter ending 2026-06-30 was $366.00K, a 17.68% increase year-over-year.
- NEPHROS, INC. research and development expense for the quarter ending 2026-03-31 was $346.00K, a 17.29% increase year-over-year.
- NEPHROS, INC. research and development expense for the quarter ending 2025-12-31 was $395.00K, a 56.75% increase year-over-year.
- NEPHROS, INC. research and development expense for the quarter ending 2025-09-30 was $338.00K, a 79.79% increase year-over-year.
- NEPHROS, INC. research and development expense for fiscal 2025 was $1.34M, a 47.79% increase from fiscal 2024.
- NEPHROS, INC. research and development expense for fiscal 2024 was $906.00K, a 3.78% increase from fiscal 2023.
- NEPHROS, INC. research and development expense for fiscal 2023 was $873.00K, a 30.44% decline from fiscal 2022.
- NEPHROS, INC. research and development expense for fiscal 2022 was $1.25M, a 16.22% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $366.00K 10-Q · filed 2026-08-10 | $712.00K 10-Q · filed 2026-08-10 | $1.11M derived: sum of 3 quarters · filed 2026-08-10 | $1.45M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $346.00K 10-Q · filed 2026-05-07 | $741.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.08M derived: sum of 3 quarters · filed 2026-05-07 | $1.39M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $395.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $733.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.04M derived: sum of 3 quarters · filed 2026-08-10 | $1.34M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $338.00K 10-Q · filed 2025-11-06 | $649.00K derived: sum of 2 quarters · filed 2026-08-10 | $944.00K 10-Q · filed 2025-11-06 | $1.20M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $311.00K 10-Q · filed 2026-08-10 | $606.00K 10-Q · filed 2026-08-10 | $858.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.05M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $295.00K 10-Q · filed 2026-05-07 | $547.00K derived: sum of 2 quarters · filed 2026-05-07 | $735.00K derived: sum of 3 quarters · filed 2026-05-07 | $989.00K derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $440.00K derived: sum of 2 quarters · filed 2026-03-12 | $694.00K derived: sum of 3 quarters · filed 2026-03-12 | $906.00K 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | $188.00K 10-Q · filed 2025-11-06 | $442.00K derived: sum of 2 quarters · filed 2025-11-06 | $654.00K 10-Q · filed 2025-11-06 | $862.00K derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $254.00K 10-Q · filed 2025-08-07 | $466.00K 10-Q · filed 2025-08-07 | $674.00K derived: sum of 3 quarters · filed 2025-08-07 | $879.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $212.00K 10-Q · filed 2025-05-15 | $420.00K derived: sum of 2 quarters · filed 2025-05-15 | $625.00K derived: sum of 3 quarters · filed 2025-05-15 | $846.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $413.00K derived: sum of 2 quarters · filed 2025-03-24 | $634.00K derived: sum of 3 quarters · filed 2025-03-24 | $873.00K 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | $205.00K 10-Q · filed 2024-11-14 | $426.00K derived: sum of 2 quarters · filed 2024-11-14 | $665.00K 10-Q · filed 2024-11-14 | $1.02M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $221.00K 10-Q · filed 2024-08-08 | $460.00K 10-Q · filed 2024-08-08 | $819.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.07M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $239.00K 10-Q · filed 2024-05-09 | $598.00K derived: sum of 2 quarters · filed 2024-05-09 | $850.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.12M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $611.00K derived: sum of 2 quarters · filed 2024-03-15 | $884.00K derived: sum of 3 quarters · filed 2024-03-15 | $1.25M 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | $252.00K 10-Q · filed 2023-11-08 | $525.00K derived: sum of 2 quarters · filed 2023-11-08 | $896.00K 10-Q · filed 2023-11-08 | $1.23M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $273.00K 10-Q · filed 2023-08-09 | $431.00K 10-Q · filed 2022-08-15 | $645.00K 10-Q · filed 2023-08-09 | $1.01M 10-Q · filed 2022-08-15 | $973.00K derived: sum of 3 quarters · filed 2023-08-09 | $1.37M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | $372.00K 10-Q · filed 2023-05-10 | $578.00K 10-Q · filed 2022-05-05 | $700.00K derived: sum of 2 quarters · filed 2023-05-10 | $1.09M derived: sum of 3 quarters · filed 2023-05-10 | $1.58M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | $328.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $723.00K derived: sum of 2 quarters · filed 2023-03-23 | $1.21M derived: sum of 3 quarters · filed 2023-03-23 | $1.50M 10-K · filed 2023-03-23 | $2.17M 10-K · filed 2022-03-03 | |||
| 2021-09-30 | $395.00K 10-Q · filed 2022-11-15 | $632.00K 10-Q · filed 2021-11-04 | $882.00K derived: sum of 2 quarters · filed 2022-11-15 | $1.17M 10-Q · filed 2022-11-15 | $1.68M 10-Q · filed 2021-11-04 | $2.05M derived: sum of 4 quarters · filed 2022-11-15 | ||
| 2021-06-30 | $487.00K 10-Q · filed 2022-08-15 | $1.04M 10-Q · filed 2022-08-15 | $1.65M derived: sum of 3 quarters · filed 2022-08-15 | $2.40M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $556.00K 10-Q · filed 2022-05-05 | $1.17M derived: sum of 2 quarters · filed 2022-05-05 | $1.92M derived: sum of 3 quarters · filed 2022-05-05 | $2.75M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $609.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $1.36M derived: sum of 2 quarters · filed 2022-03-03 | $2.20M derived: sum of 3 quarters · filed 2022-03-03 | $2.76M 10-K · filed 2022-03-03 | ||||
| 2020-09-30 | $751.00K 10-Q · filed 2021-11-04 | $1.59M derived: sum of 2 quarters · filed 2021-11-04 | $2.15M 10-Q · filed 2021-11-04 | $2.91M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $836.00K 10-Q · filed 2021-08-05 | $1.40M 10-Q · filed 2021-08-05 | $2.16M derived: sum of 3 quarters · filed 2021-08-05 | $2.94M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $563.00K 10-Q · filed 2021-05-06 | $1.33M derived: sum of 2 quarters · filed 2021-05-06 | $2.10M derived: sum of 3 quarters · filed 2021-05-06 | $2.90M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $764.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.54M derived: sum of 2 quarters · filed 2021-03-01 | $2.33M derived: sum of 3 quarters · filed 2021-03-01 | $3.09M 10-K · filed 2021-03-01 | ||||
| 2019-09-30 | $777.00K 10-Q · filed 2020-11-05 | $1.57M derived: sum of 2 quarters · filed 2020-11-05 | $2.33M 10-Q · filed 2020-11-05 | $2.87M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $793.00K 10-Q · filed 2020-08-05 | $1.55M 10-Q · filed 2020-08-05 | $2.10M derived: sum of 3 quarters · filed 2020-08-05 | $2.45M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | $756.00K 10-Q · filed 2020-05-06 | $1.30M derived: sum of 2 quarters · filed 2020-05-06 | $1.65M derived: sum of 3 quarters · filed 2020-05-06 | |||||
| 2018-12-31 | $546.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $898.00K derived: sum of 2 quarters · filed 2020-02-27 | $1.54M 10-K · filed 2020-02-27 | |||||
| 2018-09-30 | $352.00K 10-Q · filed 2019-11-06 | $993.00K 10-Q · filed 2019-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |